POLE and cancer: Consistently, in the DFCI cohort, the highest prevalence of MMR/proof-reading polymerases mutations is in double BRAF and PIK3CA mutant colorectal cancers with the exception of POLE which shows the highest mutation prevalence in BRAF mutant cancers without PIK3CA mutations (Figure 3B).